Literature DB >> 33763452

Membrane Remodeling by Arc/Arg3.1.

Per Niklas Hedde1,2, Leonel Malacrida3,4, Barbara Barylko5, Derk D Binns5, Joseph P Albanesi5, David M Jameson1.   

Abstract

The activity-regulated cytoskeletal-associated protein (Arc, also known as Arg3.1) is an immediate early gene product induced by activity/experience and required for multiple modes of synaptic plasticity. Both long-term potentiation (LTP) and long-term depression (LTD) are impaired upon Arc deletion, as well as the ability to form long-term spatial, taste and fear memories. The best-characterized cellular function of Arc is enhancement of the endocytic internalization of AMPA receptors (AMPARs) in dendritic spines. Solution of the crystal structure of a C-terminal segment of Arc revealed a striking similarity to the capsid domain of HIV Gag. It was subsequently shown that Arc assembles into viral capsid-like structures that enclose Arc mRNA, are released into the extracellular space, and are internalized by neighboring cells. Thus, Arc is unique in participating in plasma membrane budding both into and out of the cell. In this report we study the interaction of Arc with membranes using giant unilamellar vesicles (GUVs). Using the fluorescent lipid probe LAURDAN, we find that Arc promotes the formation of smaller vesicles that penetrate into the GUV interior. Our results suggest that Arc induces negative membrane curvature and may therefore facilitate the formation of mRNA-containing extracellular vesicles from the plasma membrane.
Copyright © 2021 Hedde, Malacrida, Barylko, Binns, Albanesi and Jameson.

Entities:  

Keywords:  Arc; GUV; fluorescence; giant unilamellar vesicle; membrane budding; membrane remodeling

Year:  2021        PMID: 33763452      PMCID: PMC7982473          DOI: 10.3389/fmolb.2021.630625

Source DB:  PubMed          Journal:  Front Mol Biosci        ISSN: 2296-889X


  1 in total

1.  High-affinity anti-Arc nanobodies provide tools for structural and functional studies.

Authors:  Sigurbjörn Markússon; Erik I Hallin; Helene J Bustad; Arne Raasakka; Ju Xu; Gopinath Muruganandam; Remy Loris; Aurora Martinez; Clive R Bramham; Petri Kursula
Journal:  PLoS One       Date:  2022-06-07       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.